These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33130397)

  • 61. Further biochemical and kinetic characterization of human eukaryotic initiation factor 4H.
    Richter NJ; Rogers GW; Hensold JO; Merrick WC
    J Biol Chem; 1999 Dec; 274(50):35415-24. PubMed ID: 10585411
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Flotilin-1 promotes the tumorigenicity and progression of malignant phenotype in human lung adenocarcinoma.
    Guo AY; Liang XJ; Liu RJ; Li XX; Bi W; Zhou LY; Tang CE; Yan A; Chen ZC; Zhang PF
    Cancer Biol Ther; 2017 Sep; 18(9):715-722. PubMed ID: 28825855
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma.
    Chen KJ; Huang JH; Shih JH; Gu DL; Lee SS; Shen R; Hsu YH; Kung YC; Wu CY; Ho CM; Jen HW; Lee HY; Lang YD; Hsiao CH; Jou YS
    Mol Carcinog; 2023 Mar; 62(3):348-359. PubMed ID: 36453714
    [TBL] [Abstract][Full Text] [Related]  

  • 64. METTL3-mediated m
    Wu Y; Chang N; Zhang Y; Zhang X; Xu L; Che Y; Qiao T; Wu B; Zhou Y; Jiang J; Xiong J; Zhang J; Zhang J
    J Exp Clin Cancer Res; 2021 Mar; 40(1):90. PubMed ID: 33676554
    [TBL] [Abstract][Full Text] [Related]  

  • 65. RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation.
    Bechara EG; Sebestyén E; Bernardis I; Eyras E; Valcárcel J
    Mol Cell; 2013 Dec; 52(5):720-33. PubMed ID: 24332178
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Wild-Type U2AF1 Antagonizes the Splicing Program Characteristic of U2AF1-Mutant Tumors and Is Required for Cell Survival.
    Fei DL; Motowski H; Chatrikhi R; Prasad S; Yu J; Gao S; Kielkopf CL; Bradley RK; Varmus H
    PLoS Genet; 2016 Oct; 12(10):e1006384. PubMed ID: 27776121
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Co- and post-transcriptional regulation of Rbm5 and Rbm10 in mouse cells as evidenced by tissue-specific, developmental and disease-associated variation of splice variant and protein expression levels.
    Ozuemba B; Masilamani TJ; Loiselle JJ; Koenderink B; Vanderbeck KA; Knee J; Larivière C; Sutherland LC
    Gene; 2016 Apr; 580(1):26-36. PubMed ID: 26784654
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The splicing factor RBM4 controls apoptosis, proliferation, and migration to suppress tumor progression.
    Wang Y; Chen D; Qian H; Tsai YS; Shao S; Liu Q; Dominguez D; Wang Z
    Cancer Cell; 2014 Sep; 26(3):374-389. PubMed ID: 25203323
    [TBL] [Abstract][Full Text] [Related]  

  • 70. YTHDF1 Promotes Cyclin B1 Translation through m
    Lou X; Ning J; Liu W; Li K; Qian B; Xu D; Wu Y; Zhang D; Cui W
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359836
    [TBL] [Abstract][Full Text] [Related]  

  • 71. SRSF1 modulates PTPMT1 alternative splicing to regulate lung cancer cell radioresistance.
    Sheng J; Zhao Q; Zhao J; Zhang W; Sun Y; Qin P; Lv Y; Bai L; Yang Q; Chen L; Qi Y; Zhang G; Zhang L; Gu C; Deng X; Liu H; Meng S; Gu H; Liu Q; Coulson JM; Li X; Sun B; Wang Y
    EBioMedicine; 2018 Dec; 38():113-126. PubMed ID: 30429088
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Rbm10 regulates inflammation development via alternative splicing of Dnmt3b.
    Atsumi T; Suzuki H; Jiang JJ; Okuyama Y; Nakagawa I; Ota M; Tanaka Y; Ohki T; Katsunuma K; Nakajima K; Hasegawa Y; Ohara O; Ogura H; Arima Y; Kamimura D; Murakami M
    Int Immunol; 2017 Dec; 29(12):581-591. PubMed ID: 29309623
    [TBL] [Abstract][Full Text] [Related]  

  • 73. CASC5 is a potential tumour driving gene in lung adenocarcinoma.
    Cui Y; Zhang C; Ma S; Guo W; Cao W; Guan F
    Cell Biochem Funct; 2020 Aug; 38(6):733-742. PubMed ID: 32283571
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway.
    Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H
    Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503
    [TBL] [Abstract][Full Text] [Related]  

  • 76. ESRP1 regulates alternative splicing of CARM1 to sensitize small cell lung cancer cells to chemotherapy by inhibiting TGF-β/Smad signaling.
    Zheng M; Niu Y; Bu J; Liang S; Zhang Z; Liu J; Guo L; Zhang Z; Wang Q
    Aging (Albany NY); 2021 Jan; 13(3):3554-3572. PubMed ID: 33495408
    [TBL] [Abstract][Full Text] [Related]  

  • 77. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
    Lu GS; Li M; Xu CX; Wang D
    Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
    Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
    Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
    [TBL] [Abstract][Full Text] [Related]  

  • 79. LncRNA LINC00680 promotes lung adenocarcinoma growth via binding to GATA6 and canceling GATA6-mediated suppression of SOX12 expression.
    Sun X; Wang R; Tan M; Tian X; Meng J
    Exp Cell Res; 2021 Aug; 405(1):112653. PubMed ID: 34029572
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The essential roles of m
    Ma L; Xue X; Zhang X; Yu K; Xu X; Tian X; Miao Y; Meng F; Liu X; Guo S; Qiu S; Wang Y; Cui J; Guo W; Li Y; Xia J; Yu Y; Wang J
    J Exp Clin Cancer Res; 2022 Jan; 41(1):36. PubMed ID: 35078505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.